Plenary events
-
EQ-5D-Y Indonesia and the Drop-down Method
Titi Sahidah Fitriana (Erasmus University) will present her studies bringing EQ-5D-Y as a ready to used instrument in Indonesia. Xin Zhang (University Medical Center Groningen) will present a new drop-down method in preference-based health-outcome measurement. After their brief presentations (15 minutes each), they will answer questions from discussants Michael Herdman (National University of Singapore) and Paul Schneider (University of Sheffield) as well as attendees.
-
Health Valuation and the EQ-VT
This Core Knowledge Panel (90 min) starts with an introduction to health valuation by Michał Jakubczyk (SGH Warsaw School of Economics), who chairs the Valuation Working Group. After this overview, Juan Manuel Ramos Goñi (Maths in Health) will describe the EQ-VT valuation protocol. Jonathan Nazari and Rachel Lee-Yin Tan (Network members) will narrate their first hand experiences as EQ-VT interviewers and serve as discussants. After these presentations, attendees will…
-
EQ-5D-5L in RCTs and in comparison with EQ-HWB
Jiajun Yan (McMaster University) will present statistical methods for analyzing EQ-5D-5L data in randomized clinical trials. Maja Kuharic (University of Illinois at Chicago) will compare EQ-HWB/EQ-HWB-S with the EQ-5D-5L and other preference-based measures among US informal caregivers. After their brief presentations (15 minutes each), they will answer questions from discussants Yan Feng and Tessa Peasgood (Group members) as well as attendees (~30…
-
EQ-5D clinical dashboards and EQ-HWB DCE
At this Student Research Webinar (60 min), Anja Yvonne Bischof (University of St. Gallen, St. Gallen, Switzerland) will present her recent research on the inclusion of the EQ-5D on clinical dashboards in combination with disease-specific patient-reported outcomes measures. Haode Wang (University of Sheffield, Sheffield, United Kingdom) will present on DCE valuation of the EQ-HWB descriptive system in UK and…
-
Choice analysis in health valuation
At this Student Research Webinar (60 min), Maksat Jumamyradov (University of South Florida, Tampa, USA) will present his three recent papers on choice analysis in health valuation, describing biases in conditional and mixed logit estimates when preferences are heterogeneous. After his presentation (30 minutes), he will answer questions from David Mott (OHE, London, UK) and Yiting Luo (Centre for Health Economics…
-
EQ-5D-Y Singapore and TTO Distortion
Rachel Lee-Yin Tan (National University of Singapore) will present her research on the EQ-5D-Y as a preference-based HRQoL instrument for use in paediatrics in Singapore. Zhongyu Lang (Erasmus University) will present his findings employing episodic future thinking to reduce the distortion of time preference in time trade-off (TTO). After their brief presentations (15 minutes each), they will answer…
-
Assessing Population Health
This Core Knowledge Panel (90 min) starts with an introduction to the assessment of population health by Juanita Haagsma (Erasmus MC), who co-chairs the Populations and Health Systems Working Group. After this overview, Fatima Al Sayah (University of Alberta) will introduce the EuroQol – Data for Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)…
-
The Validity of the EQ-5D in Clinical Practice and among Indigenous People
Irene Salvi (University of St. Gallen) will present her research on minimal important differences (MID) of EQ-5D-3L index score improvements adjusted for different patient characteristics after hip and knee replacements. Lilla Roy (University of Alberta) will share what she has learned about how valid the EQ-5D-5L might be for Indigenous people living in urban Alberta,…
-
How the EuroQol Office can help you
This Core Knowledge Panel (90 min) starts with an introduction to the EuroQol Office by Bernhard Slaap (Executive Director, EuroQol Research Foundation, Rotterdam, the Netherlands). After this overview, James W. Shaw (Executive Director and Head, Patient-Reported Outcomes Assessment, WWHEOR at Bristol Myers Squibb) and Caitlyn T. Solem (Director, Pipeline Strategy, US Oncology Value Evidence and…
-
EQ-5D-5L in obstructive airway disease
Ai Ping Chua (National University of Singapore) will present the appraisal of the EQ-5D-5L in the obstructive airway diseases using a longer recall period and frequency-based responses. After this brief presentation, the presenter will answer a few questions from Bernhard Michalowsky (German Center for Neurodegenerative Diseases [DZNE]) as well as attendees.
Last update: Feb 6, 2024